Side Effects Profile in Humans of 11C-(+)-PHNO, a Dopamine D2/3 Agonist Ligand for PET

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Nuclear Medicine

• Publication date

  2010-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2967/jnumed.109.072314PMID 20150251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients

  2009cited by this paper
• Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC.

  2008cited by this paper
• A fully automated synthesis for the preparation of 68Ga-labelled peptides

  2007cited by this paper
• Sliding scale insulin use: myth or insanity?

  2007cited by this paper
• Better glycemic control in the hospital: beneficial and feasible.

  2007cited by this paper
• Processing of Generator-Produced 68Ga for Medical Application

  2007cited by this paper
• Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

  2006cited by this paper
• Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]‐(+)‐PHNO is a D3 receptor preferring agonist in vivo

  2006cited by this paper
• High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.

  2006cited by this paper
• Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.

  2005cited by this paper
• Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity.

  2004cited by this paper
• FDG-PET: procedure guidelines for tumour imaging

  2003cited by this paper
• Clinical 18F-FDG oncology patient preparation techniques.

  2003cited by this paper
• Clinical PET in oncology.

  2000cited by this paper
• A dopamine D3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog.

  1995cited by this paper
• Nasogastric and intravenous infusions of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's disease.

  1990cited by this paper
• Sustained‐release (+)‐PHNO [MK‐458 (HPMC)] in the treatment of Parkinson's disease: Evidence for tolerance to a selective D2‐receptor agonist administered as a long‐acting formulation

  1990cited by this paper
• Antiparkinsonian activity of single oral dose of PHNO

  1987cited by this paper

• Radiotracers for imaging of schizophrenia.

  2026cites this paper
• Exceptional brain PET images from the NeuroEXPLORER: scans with targeted radiopharmaceuticals and comparison to HRRT

  2025cites this paper
• Carotid Artery Image-Derived Blood Time–Activity Curves on the NeuroEXPLORER: Initial Multitracer Validation Against Arterial Sampling

  2025cites this paper
• Molecular brain imaging of psychedelic action.

  2025cites this paper
• Effect of scan-time shortening on the 11C-PHNO binding potential to dopamine D3 receptor in humans and test–retest reliability

  2023cites this paper
• Noninvasive Quantitative PET Imaging in Humans of the Pancreatic Beta-Cell Mass Biomarkers VMAT2 and Dopamine D2/D3 Receptors In Vivo.

  2023cites this paper
• EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality

  2021cites this paper
• Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.

  2021cites this paper
• University of Groningen Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers

  2019cites this paper
• Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging

  2018cites this paper
• Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry

  2018cites this paper
• Development of 18F-labeled agonist radioligands for PET imaging of the high-affinity state of cerebral dopamine D2/3 receptors

  2017cites this paper
• The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11C]‐raclopride and [11C]‐(+)‐PHNO PET

  2017cites this paper
• Imaging Nicotine- and Amphetamine-Induced Dopamine Release in Rhesus Monkeys with [11C]PHNO vs [11C]raclopride PET

  2014cites this paper
• Imaging Alcohol Induced Dopamine Release in the Human Brain: a PET/[11C]-(+)-PHNO Study

  2014cites this paper
• Dopamine Receptors and Dopamine Release

  2014cites this paper
• Mathematical modelling of [11C]-(+)-PHNO human competition studies

  2013cites this paper
• Molecular imaging of dopamine synthesis and release

  2013influential citation
• Characterization of fast-decaying PET radiotracers solely through LC-MS/MS of constituent radioactive and carrier isotopologues

  2013cites this paper
• Post-processing via cation exchange cartridges: versatile options.

  2013cites this paper
• Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [11C]-(+)-PHNO PET Study

  2013cites this paper
• Test-retest reproducibility of [11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm.

  2013cites this paper
• Whole-Body Distribution and Radiation Dosimetry of 11C-(+)-PHNO, a D2/3 Agonist Ligand

  2012cites this paper
• Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.

  2012cites this paper
• Affinity and selectivity of [11C]‐(+)‐PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo

  2012cites this paper
• Automated preparation of the dopamine D2/3 receptor agonist ligand [11C]-(+)-PHNO for human PET imaging studies.

  2012cites this paper
• Mass dose effects and in vivo affinity in brain PET receptor studies--a study of cerebral 5-HT4 receptor binding with [11C]SB207145.

  2011cites this paper
• Neurogenetics and Nutrigenomics of Reward Deficiency Syndrome

  2011cites this paper
• Assessment of Dopamine and Serotonin Release in the Non-Human Primate Brain using PET

  2011cites this paper
• Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.

  2011cites this paper
• Current state of agonist radioligands for imaging of brain dopamine D2/D3 receptors in vivo with positron emission tomography.

  2010cites this paper